Background: Apocrine mixed tumor is usually found in parotid glands. Its cutaneous counterpart is rare and its occurrence in the eyelids is even rarer.
Case Presentation: This study reports an apocrine mixed tumor of the upper left eyelid in a 68 year-old lady with a history of breast cancer. This mass appeared about 3 years ago, as a slowly growing small nodule, and was completely excised. On microscopic examination, an encapsulated mass with epithelial and mesenchymal features was seen. The epithelial component presented tubular, cystic and infundibular structures while the mesenchymal component was fibrous in some areas and myxoid in others. Plasmacytoid hyaline cells, lipomatous change and focal calcification were appreciated focally. Immunohistochemical studies showed stromal staining for CD10, S-100, α-SMA and p63. Luminal cell layer of the epithelial component was positive for EMA, CK-7 and GCDFP-15 markers. The capsule was unbreached and no satellite lesions were appreciated. No evidence of relapse was evident after 16 months of follow-up.
Conclusions: The diagnosis of eyelid tumors of adnexal origin can be challenging because they are rare and display a wide range of morphological patterns, as the tumor cells might differentiate along any line of the folliculosebaceous-apocrine system. Immunohistochemistry helps improve the accuracy of assessment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806417 | PMC |
| http://dx.doi.org/10.1186/s13000-016-0483-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The effect of smoking on Sjögren's disease development and severity: a comprehensive literature review.
Clin Exp Rheumatol
December 2024
Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, and National Institute of Health Research (NIHR) Birmingham Biomedical Research Centre and Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Unlike other autoimmune diseases, little is known about the environmental risk factors for Sjögren's disease (SjD). Smoking is an important risk factor for rheumatoid arthritis but the relationship between smoking and SjD is more complex to understand. Current smoking seems to be negatively linked to SjD, whereas there is mixed data on past smoking.
View Article and Find Full Text PDFSerum exocrine pancreas enzymes are biomarkers of immunotherapy response in new-onset type 1 diabetes.
Front Endocrinol (Lausanne)
December 2024
Division of Endocrinology, Department of Pediatrics, University of Florida, Gainesville, FL, United States.
Introduction: The immune-mediated destruction of insulin-producing β-cells characterizes type 1 diabetes. Nevertheless, exocrine pancreatic enzymes, including amylase, lipase, and trypsin, are also significantly reduced in type 1 diabetes. With an immunotherapy now approved to treat early-stage type 1 diabetes, biomarkers to delineate response to treatment are needed.
View Article and Find Full Text PDFChondroid syringoma on the nasal wing: A case report in a 22-year-old male.
Int J Surg Case Rep
December 2024
Department of Dermatology, Faculty of Medicine, University of Aleppo, Aleppo, Syria.
Introduction And Importance: Chondroid syringoma also referred to as a mixed tumor, is a benign and rare tumor originating from apocrine or eccrine sweat glands; it predominantly affects middle-aged men. While fine-needle aspiration cytology can aid in diagnosis, histological confirmation remains essential due to the potential for misdiagnosis.
Case Presentation: A-22-year-old male who presented with a solitary, slow-growing, painless, erythematous nodule on the right nasal wing that had been present for 1 year, which was misdiagnosed as an epidermal cyst.
Exploring the molecular landscape of cutaneous mixed tumors characterized by TRPS1::PLAG1 gene fusion.
J Pathol
December 2024
Department of Pathology, Institute de Pathologie Multisite, Groupement Hospitalier Sud, Lyon University Hospital, Pierre-Bénite, France.
The histological similarities between pleomorphic adenomas (PAs) and cutaneous mixed tumors (CMTs) found in certain facial regions can create a diagnostic challenge. Molecular findings reveal common genetic profiles, particularly PLAG1 rearrangements in both PA and CMT. Although molecular distinctions have received limited attention, our observations indicate multiple cases of CMTs carrying the TRPS1::PLAG1 fusion.
View Article and Find Full Text PDFExternal Validation of a Previously Developed Deep Learning-based Prostate Lesion Detection Algorithm on Paired External and In-House Biparametric MRI Scans.
Radiol Imaging Cancer
November 2024
From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.).
Article Synopsis
- A study evaluated an AI model's ability to detect prostate cancer in scans done at different institutions, focusing on biparametric MRI (bpMRI) scans from both an external and an in-house setup.
- This research included 201 male patients and showed that the AI detected a greater percentage of lesions on in-house scans compared to external ones (56.0% vs. 39.7% for intraprostatic lesions and 79% vs. 61% for clinically significant prostate cancer).
- Factors that improved the AI's detection rates included higher PI-RADS scores, larger lesion sizes, and better quality of diffusion-weighted MRI images.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!